Ribeiro Ramiro 4
4 · EyePoint, Inc. · Filed Jan 7, 2026
Insider Transaction Report
Form 4
EyePoint, Inc.EYPT
Ribeiro Ramiro
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2026-01-05$8.26/sh+29,250$241,605→ 42,544 total - Sale
Common Stock
2026-01-05$17.10/sh−42,544$727,319→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2026-01-05−29,250→ 87,750 totalExercise: $8.26Exp: 2035-01-03→ Common Stock (29,250 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.68 to $17.51. The reporting person undertakes to provide EyePoint Inc., any security holder of EyePoint Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The option to purchase will vest and become exercisable as follows: 25% at January 3, 2026 and the remainder ratably, on a monthly basis, over the remaining three years.